These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 225051)

  • 1. [Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].
    Bataille D; Peillon F; Besson J; Rosselin G
    C R Seances Acad Sci D; 1979 May; 288(17):1315-7. PubMed ID: 225051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
    Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes.
    Dharmsathaphorn K; Harms V; Yamashiro DJ; Hughes RJ; Binder HJ; Wright EM
    J Clin Invest; 1983 Jan; 71(1):27-35. PubMed ID: 6294141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
    Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
    Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
    Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
    Prieto JC; Guerrero JM; de Miguel C; Goberna R
    Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts.
    Beed EA; O'Dorisio MS; O'Dorisio TM; Gaginella TS
    Regul Pept; 1983 Apr; 6(1):1-12. PubMed ID: 6306732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Receptors for vasoactic intestinal peptide (VIP) in human colonic adenocarcinoma membranes: specific binding and stimulation of adenylate cyclase].
    Dupont C; Amiranoff B; Laburthe M; Rosselin G
    C R Acad Hebd Seances Acad Sci D; 1978 Jan; 286(2):209-12. PubMed ID: 206381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
    Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
    Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1986 Aug; 159(1):45-9. PubMed ID: 3017717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intestinal vasoactive peptide receptors in enterocytes : specific binding and stimulation of cyclic AMP].
    Laburthe M; Besson J; Bon Hoa DH; Rosselin G
    C R Acad Hebd Seances Acad Sci D; 1977 Jun; 284(21):2139-42. PubMed ID: 195749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes.
    Robberecht P; Waelbroeck M; Camus JC; De Neef P; Christophe J
    Biochim Biophys Acta; 1984 Jun; 773(2):271-8. PubMed ID: 6329286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP stimulates ACTH release and adenylate cyclase in human ACTH-secreting pituitary adenomas.
    Oliva D; Nicosia S; Spada A; Giannattasio G
    Eur J Pharmacol; 1982 Sep; 83(1-2):101-5. PubMed ID: 6290240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase.
    Nicosia S; Spada A; Borghi C; Cortelazzi L; Giannattasio G
    FEBS Lett; 1980 Apr; 112(2):159-62. PubMed ID: 6768592
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
    Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.